Applied Therapeutics Extends Tender Offer by One Day, Only 41.29% Shares Tendered

summarizeSummary

Applied Therapeutics has extended its tender offer by Cycle Group Holdings for one day to January 28, 2026, with only 41.29% of outstanding shares tendered as of the previous deadline.

check_boxKey Events

• Tender Offer Extended

  The tender offer by Cycle Group Holdings has been extended by one day, now set to expire at 11:59 p.m. Eastern time on January 28, 2026.

• Low Share Tender Rate Reported

  As of January 27, 2026, approximately 63,684,636 shares, representing only 41.29% of outstanding shares, have been validly tendered.

• Board Continues Recommendation

  The company's board continues to recommend shareholders accept the offer of $0.088 cash per share plus one contingent value right (CVR).

auto_awesomeAnalysis

Applied Therapeutics has extended the tender offer from Cycle Group Holdings for an additional day, now expiring on January 28, 2026. This marks a critical update to the ongoing acquisition process, following the board's unanimous recommendation on January 21, 2026. The most significant detail is the low tender rate, with only 41.29% of outstanding shares submitted by the previous deadline. This low participation, coupled with a very short, one-day extension, suggests potential challenges in securing shareholder acceptance for the $0.088 cash plus CVR offer. Investors should monitor whether the remaining conditions for the offer's consummation can be met swiftly, given the tight deadline and the current tender rate.